Patent Assignment
Reel/Frame 055429/0489
Merger
Recorded: 2021-02-26
Pages: 6
Assignor
DISTRIBUTED BIO, INC.
Executed: 2020-12-31
Assignee
CHARLES RIVER LABORATORIES, INC.
251 BALLARDVALE STREET, WILMINGTON, MASSACHUSETTS, 01887
Covered Properties
(3)
Anti-Sars-Cov-2 Antibodies and Uses Thereof
Application:
62/993,630 →
Anti-Sars-Cov-2 Antibodies Derived from 2DD8
Application:
63/014,946 →
Anti-Sars-Cov-2 Antibodies Derived from 2DD8
Patent:
11,028,150 →
Application:
15/931,642 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 26, 2021
From: GLANVILLE, JACOB; DARAEIKIA, SHAHRAD; WANG, I-CHIEH; LIAO CHAN, SINDY ANDREA
To: DISTRIBUTED BIO, INC.
Reel/Frame 055541/0062 →
Assignment of Assignor's Interest
Feb 26, 2021
From: GLANVILLE, JACOB; DARAEIKIA, SHAHRAD; WANG, I-CHIEH; LIAO CHAN, SINDY ANDREA
To: DISTRIBUTED BIO, INC.
Reel/Frame 055542/0112 →
Assignment of Assignor's Interest
Feb 26, 2021
From: GLANVILLE, JACOB; DARAEIKIA, SHAHRAD; WANG, I-CHIEH; LIAO CHAN, SINDY ANDREA
To: DISTRIBUTED BIO, INC.
Reel/Frame 055542/0124 →
Assignment of Assignor's Interest
Mar 16, 2021
From: CHARLES RIVER LABORATORIES, INC.
To: CENTIVAX, INC.
Reel/Frame 055605/0163 →